Mithradote Bio

San Diego, United States

Mithradote Bio is a biotechnology company developing a novel medication to help prevent drug-facilitated sexual assault.

$1.0M raised

Oct 2024

Seed

Biotechnology Life Science

Top Investors

Vickers Venture PartnersTaho Pharmaceuticals

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Mithradote Bio

How much funding has Mithradote Bio raised?

Mithradote Bio has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in October 2024.

Who are Mithradote Bio's investors?

Mithradote Bio's investors include Vickers Venture Partners, Taho Pharmaceuticals.

Where is Mithradote Bio headquartered?

Mithradote Bio is headquartered in San Diego, United States.

What does Mithradote Bio do?

Mithradote Bio is a biotechnology company developing a novel medication to help prevent drug-facilitated sexual assault.

What stage is Mithradote Bio at?

Mithradote Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 2, 2024.

MLA

"Mithradote Bio — Funding & Investors." VCBacked, October 2, 2024, https://www.vcbacked.co/company/mithradote-bio. Accessed June 17, 2026.

APA

VCBacked. (2024). Mithradote Bio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/mithradote-bio

Wikipedia (cite web)

{{cite web |title=Mithradote Bio — Funding & Investors |url=https://www.vcbacked.co/company/mithradote-bio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 2, 2024.

Similar Companies in Biotechnology